The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 10, 2019

Filed:

Dec. 28, 2015
Applicant:

Nitto Denko Corporation, Osaka, JP;

Inventors:

Kenjirou Minomi, Osaka, JP;

Jens Harborth, San Diego, CA (US);

Cima Cina, San Diego, CA (US);

Kwok Yin Tsang, Irvine, CA (US);

Wenbin Ying, San Diego, CA (US);

Hirokazu Takahashi, Osaka, JP;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/113 (2010.01); C07H 21/02 (2006.01); C07H 21/04 (2006.01); C07F 9/6533 (2006.01); C12Q 1/02 (2006.01); G01N 33/58 (2006.01); A61B 5/00 (2006.01); A61K 49/00 (2006.01); C07D 311/30 (2006.01); A61K 31/713 (2006.01);
U.S. Cl.
CPC ...
A61B 5/0071 (2013.01); A61K 49/0021 (2013.01); C07D 311/30 (2013.01); C07F 9/6533 (2013.01); C12N 15/113 (2013.01); C12N 15/1135 (2013.01); C12N 15/1137 (2013.01); C12Q 1/02 (2013.01); G01N 33/582 (2013.01); H05K 999/99 (2013.01); A61K 31/713 (2013.01); C12N 2310/14 (2013.01); C12N 2310/322 (2013.01); C12N 2310/344 (2013.01); C12N 2310/3515 (2013.01); C12N 2310/531 (2013.01); C12N 2320/30 (2013.01); C12N 2320/32 (2013.01); C12N 2320/35 (2013.01); C12N 2320/53 (2013.01);
Abstract

This invention provides compounds, compositions and methods for modulating the expression of human p21 using RNA interference. The RNA interference molecules can be used in methods for preventing or treating diseases such as malignant tumor. A nucleic acid molecule can have a) a polynucleotide sense strand and a polynucleotide antisense strand; b) each strand of the molecule being from 15 to 30 nucleotides in length; c) a contiguous region of from 15 to 30 nucleotides of the antisense strand being complementary to a sequence of an mRNA encoding p21; and d) at least a portion of the sense strand can be complementary to at least a portion of the antisense strand, and the molecule has a duplex region of from 15 to 30 nucleotides in length.


Find Patent Forward Citations

Loading…